As­traZeneca is leav­ing the lob­by­ing group PhRMA, third drug­mak­er to ditch trade group in last five months

As­traZeneca has joined Te­va and Ab­b­Vie in de­part­ing the US drug lob­by group Phar­ma­ceu­ti­cal Re­search and Man­u­fac­tur­ers of Amer­i­ca, say­ing it made the de­ci­sion to end its mem­ber­ship af­ter eval­u­at­ing the re­la­tion­ship.

The British drug­mak­er is the third ma­jor phar­ma to leave the group in the past five months.

“We reg­u­lar­ly eval­u­ate our mem­ber­ships with in­dus­try trade as­so­ci­a­tions,” an As­traZeneca spokesper­son said in an emailed state­ment. “Giv­en the sig­nif­i­cant in­vest­ment, we want to en­sure it is the most pro­duc­tive and ef­fec­tive use of our re­sources.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.